As the NHS cervical cancer screening programme (CSP) rolls out high risk human papilloma virus (HR-HPV) testing for the triage of women with borderline or low-grade cervical abnormalities across England, the Roche cobas HPV test has already enabled more than 30 laboratories to be ready to offer an HPV testing service. In the financial year 2011/2012, local cervical screening programmes have been preparing to present a business case for approval and central support funding (for the first two years) to support the implementation of HPV Triage and Test of Cure. Only programmes with a minimum annual workload of 35,000 can apply and the HPV assay used must be approved by NHS CSP. Currently, only five commercially available HPV tests have been approved, including the obas HPV test on the cobas 4800 instrument.
Loading ...